Literature DB >> 23804807

The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells.

Kerstin Nündel1, Patricia Busto, Michelle Debatis, Ann Marshak-Rothstein.   

Abstract

The protein kinase Btk has been implicated in the development, differentiation, and activation of B cells through its role in the BCR and TLR signaling cascades. These receptors and in particular, the BCR and either TLR7 or TLR9 also play a critical role in the activation of autoreactive B cells by RNA- or DNA-associated autoantigens. To explore the role of Btk in the development of autoreactive B cells, as well as their responses to nucleic acid-associated autoantigens, we have now compared Btk-sufficient and Btk-deficient mice that express a prototypic RF BCR encoded by H- and L-chain sdTgs. These B cells bind autologous IgG2a with low affinity and only proliferate in response to IgG2a ICs that incorporate DNA or RNA. We found that Btk-sufficient RF(+) B cells mature into naïve FO B cells, all of which express the Tg BCR, despite circulating levels of IgG2a. By contrast, a significant proportion of Btk-deficient RF(+) B cells acquires a MZ or MZ precursor phenotype. Remarkably, despite the complete inability of RF(+) Xid/y B cells to respond to F(ab')2 anti-IgM, RF(+) Xid/y B cells could respond well to autoantigen-associated ICs. These data reveal unique features of the signaling cascades responsible for the activation of autoreactive B cells.

Entities:  

Keywords:  Btk; Toll-like receptor; Xid; autoantibody; autoreactive B cells; marginal zone B cells

Mesh:

Substances:

Year:  2013        PMID: 23804807      PMCID: PMC3800065          DOI: 10.1189/jlb.0313126

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.

Authors:  F Martin; J F Kearney
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.

Authors:  A Cariappa; M Tang; C Parng; E Nebelitskiy; M Carroll; K Georgopoulos; S Pillai
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

4.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

5.  Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.

Authors:  Takuya Mizuno; Thomas L Rothstein
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

6.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

7.  Activation of autoreactive B cells by CpG dsDNA.

Authors:  Gregory A Viglianti; Christina M Lau; Timothy M Hanley; Benjamin A Miko; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

8.  B cell receptor signal strength determines B cell fate.

Authors:  Stefano Casola; Kevin L Otipoby; Marat Alimzhanov; Sibille Humme; Nathalie Uyttersprot; Jeffery L Kutok; Michael C Carroll; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

9.  Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse.

Authors:  G M Dingjan; S Middendorp; K Dahlenborg; A Maas; F Grosveld; R W Hendriks
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

10.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more
  9 in total

1.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.

Authors:  Lukas Bossaller; Anette Christ; Karin Pelka; Kerstin Nündel; Ping-I Chiang; Catherine Pang; Neha Mishra; Patricia Busto; Ramon G Bonegio; Reinhold Ernst Schmidt; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2016-06-27       Impact factor: 5.422

2.  Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation.

Authors:  Josephine R Giles; Adriana Turqueti Neves; Ann Marshak-Rothstein; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-02-23

3.  Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

Authors:  Rachel H Bonami; Allison M Sullivan; James B Case; Hannah E Steinberg; Kristen L Hoek; Wasif N Khan; Peggy L Kendall
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

4.  Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells.

Authors:  Kerstin Nündel; Purvi Mande; Stephanie L Moses; Patricia Busto; Jaime L Cullen; Madelyn R Schmidt; Mark J Shlomchik; Robert T Woodland; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

5.  Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.

Authors:  Kerstin Nündel; Nathaniel M Green; Arthur L Shaffer; Krishna L Moody; Patricia Busto; Dan Eilat; Kensuke Miyake; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

6.  Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus.

Authors:  Allison Sang; Ying Yi Zheng; Seung-Chul Choi; Leilani Zeumer; Laurence Morel
Journal:  J Leukoc Biol       Date:  2015-05-08       Impact factor: 4.962

7.  Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands.

Authors:  Sudesh Pawaria; Krishna Moody; Patricia Busto; Kerstin Nündel; Chee-Ho Choi; Tariq Ghayur; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

Review 8.  Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.

Authors:  Anne B Satterthwaite
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

Review 9.  TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.

Authors:  Amy N Suthers; Stefanie Sarantopoulos
Journal:  Front Immunol       Date:  2017-07-13       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.